DM-Pharma
ActiveSummary
The computed 12-month bankruptcy probability of DM-Pharma is 2.4% (moderate). The 2025 annual accounts show equity of €49,542 and a net result of €851. Equity grew by about 12% per year on average since 2021. In 2025 it fell by 35.3%. Its solvency ranks better than 41% of 22,793 sector peers (NACE 47, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Official details
Source: KBO- Status
- Active since 06-01-2021 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730and 2 others
- Establishment unit
- 2.311.662.230 9400 Ninove, since 06-01-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 16-09-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 2.4%
- Gross margin
- €16,838
- ▼ 68.1%
- Turnover
- ≈ €180,000
- estimated
- Profit
- €851
- ▼ 96.9%
- Equity
- €49,542
- ▼ 35.3%
- Total assets
- €217,870
- ▼ 9.6%
Score breakdownraises riskFounded in 20211 change of registered office in 24 monthsLiquidity: current ratio 0.83, cash €8,779lowers riskFigures for financial year 2025 (filed on 29-06-2026)Show the evidence
Checked score
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 38% of them on solvency, 44% on liquidity, 34% on profitability and 14% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the moderate class on 30-06-2025, 2.4% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 5 accounts on average 23 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Recent changes
- · Gazette deed Registered office moved from Ninove to AppelterreNew registered office: Terrasstraat 39, 9400 Appelterre · Previous registered office: Gezellestraat 58, 9400 Ninove
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as DM-Pharma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €190,000 and €285,000, founded between 2018 and 2022.
| Company | Total assets | Gross margin |
|---|---|---|
| DM-Pharma Ninove | €217,870 | €16,838 |
| BVV Affligem | €202,995 | €21,939 |
| PTMS CONSULTANCY Londerzeel | €192,606 | €20,091 |
| Pharmacie du Bien-être Brussels | €190,415 | €24,538 |
| PHARMACIE BARON DE CASTRO Etterbeek | €285,240 | €23,988 |
| Meli Pharm Schaerbeek | €224,525 | €24,190 |
| PHARMACIE SAIDI Sint-Gillis (bij-Brussel) | €284,436 | €25,191 |
Key facts about DM-Pharma
- What is the company number of DM-Pharma?
- The company number of DM-Pharma is 0760.881.856. The VAT number is the same number with BE in front: BE 0760.881.856.
- Where is DM-Pharma based?
- The registered office is at Terrasstraat (App) 39, 9400 Ninove.Company details
- What does DM-Pharma do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of DM-Pharma?
- DM-Pharma is a private limited company (BV).
- When was DM-Pharma founded?
- DM-Pharma was founded on 06-01-2021.
- Is DM-Pharma still active?
- Yes, DM-Pharma is an active enterprise in the KBO register.
- What is the turnover of DM-Pharma?
- The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €16,838 and 118 comparable companies (NACE 477). It probably lies between €64,000 and €370,000. It is a rough estimate.Financials
- Is DM-Pharma profitable?
- In financial year 2025, DM-Pharma made a profit of €851.
- Where can I find the annual accounts of DM-Pharma?
- DM-Pharma filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DM-Pharma due?
- DM-Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.